- Home
- ABEO vs RLTY Comparison
ABEO vs RLTY Comparison
Compare ABEO & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- RLTY
- Stock Information
- Founded
- ABEO N/A
- RLTY 2022
- Country
- ABEO United States
- RLTY United States
- Employees
- ABEO N/A
- RLTY N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- ABEO Health Care
- RLTY Finance
- Exchange
- ABEO Nasdaq
- RLTY Nasdaq
- Market Cap
- ABEO 243.9M
- RLTY 256.4M
- IPO Year
- ABEO 1980
- RLTY N/A
- Fundamental
- Price
- ABEO $6.46
- RLTY $16.32
- Analyst Decision
- ABEO Strong Buy
- RLTY
- Analyst Count
- ABEO 3
- RLTY 0
- Target Price
- ABEO $18.00
- RLTY N/A
- AVG Volume (30 Days)
- ABEO 248.5K
- RLTY 86.7K
- Earning Date
- ABEO 11-11-2024
- RLTY 01-01-0001
- Dividend Yield
- ABEO N/A
- RLTY 9.35%
- EPS Growth
- ABEO N/A
- RLTY N/A
- EPS
- ABEO N/A
- RLTY N/A
- Revenue
- ABEO N/A
- RLTY N/A
- Revenue This Year
- ABEO N/A
- RLTY N/A
- Revenue Next Year
- ABEO $7,097.06
- RLTY N/A
- P/E Ratio
- ABEO N/A
- RLTY N/A
- Revenue Growth
- ABEO 147.52
- RLTY N/A
- 52 Week Low
- ABEO $3.05
- RLTY $11.38
- 52 Week High
- ABEO $9.01
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- ABEO 67.25
- RLTY 41.86
- Support Level
- ABEO $6.06
- RLTY $16.72
- Resistance Level
- ABEO $6.48
- RLTY $17.28
- Average True Range (ATR)
- ABEO 0.33
- RLTY 0.35
- MACD
- ABEO 0.05
- RLTY -0.15
- Stochastic Oscillator
- ABEO 88.98
- RLTY 5.87
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.